SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.060
+0.020 (0.66%)
At close: Jul 31, 2026, 4:00 PM EDT
3.050
-0.010 (-0.33%)
After-hours: Jul 31, 2026, 7:01 PM EDT
SBC Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 167.31 | 163.77 | 125.04 | 103.02 | 0.49 |
Short-Term Investments | 0.31 | 0.32 | - | - | - |
Cash & Short-Term Investments | 167.62 | 164.09 | 125.04 | 103.02 | 0.49 |
Cash Growth | 26.93% | 31.23% | 21.38% | 21117.17% | - |
Accounts Receivable | 36.76 | 29.9 | 30.26 | 35.11 | - |
Other Receivables | 19.99 | 21.54 | 16.38 | 14.63 | - |
Total Trade Receivables | 56.75 | 51.44 | 46.64 | 49.74 | - |
Inventory | 2.32 | 2.79 | 1.49 | 3.09 | - |
Other Current Assets | 12.09 | 12.9 | 11.28 | 10.05 | 0.24 |
Total Current Assets | 238.78 | 231.22 | 184.45 | 165.91 | 0.72 |
Net Property, Plant & Equipment | 18.76 | 16.36 | 14.04 | 19.5 | - |
Other Intangible Assets | 47.15 | 47.74 | 1.59 | 19.74 | - |
Goodwill | 15.4 | 15.43 | 4.61 | 3.59 | - |
Long-Term Investments | 39.05 | 39.45 | 20.87 | 20.66 | - |
Other Long-Term Assets | 28.87 | 30.24 | 40.52 | 29.41 | 119.22 |
Total Assets | 388.02 | 380.45 | 266.08 | 258.81 | 119.94 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 19.7 | 17.64 | 14.53 | 26.53 | 0.08 |
Accrued Expenses | - | - | - | - | 0.08 |
Current Portion of Long-Term Debt | 8.99 | 9.1 | 0.12 | 3.53 | - |
Current Portion of Leases | 5.64 | 4.55 | 4.34 | 3.89 | - |
Unearned Revenue | 5.23 | 6.77 | 12.56 | 25.13 | - |
Other Current Liabilities | 23.02 | 23.06 | 29.63 | 33.38 | 0.41 |
Total Current Liabilities | 62.57 | 61.12 | 61.19 | 92.45 | 0.57 |
Long-Term Debt | 31.45 | 33.73 | 6.51 | 13.01 | - |
Long-Term Leases | 5.83 | 4.25 | 1.24 | 2.44 | - |
Other Long-Term Liabilities | 17.79 | 18.04 | 2.12 | 7.09 | 4.03 |
Total Long-Term Liabilities | 55.07 | 56.02 | 9.87 | 22.54 | 4.03 |
Total Liabilities | 117.64 | 117.14 | 71.06 | 115 | 4.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | - | 0.01 | 0.01 | 0.01 | 0 |
Treasury Stock | -7.75 | -7.75 | -2.7 | - | - |
Additional Paid-in Capital | 72.87 | 72.87 | 62.51 | 36.88 | - |
Accumulated Other Comprehensive Income | -61.54 | -57.29 | -54.18 | -37.58 | - |
Retained Earnings | 251.76 | 240.45 | 189.46 | 142.85 | -3.36 |
Total Common Shareholders' Equity | 255.34 | 248.28 | 195.11 | 142.16 | -3.36 |
Minority Interest | 15.04 | 15.02 | -0.09 | 1.65 | 118.71 |
Shareholders' Equity | 270.38 | 263.3 | 195.02 | 143.81 | -3.36 |
Total Liabilities & Equity | 388.02 | 380.45 | 266.08 | 258.81 | 119.94 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 51.9 | 51.64 | 12.21 | 22.87 | 0 |
Net Cash (Debt) | 115.72 | 112.46 | 112.83 | 80.16 | 0.49 |
Net Cash Growth | -1.90% | -0.33% | 40.76% | 16407.90% | - |
Net Cash Per Share | 1.13 | 1.09 | 1.17 | 0.85 | 0.06 |
Book Value | 255.34 | 248.28 | 195.11 | 142.16 | -3.36 |
Book Value Per Share | 2.48 | 2.41 | 2.02 | 1.51 | -0.42 |
Tangible Book Value | 192.79 | 185.11 | 188.91 | 118.83 | -3.36 |
Tangible Book Value Per Share | 1.87 | 1.80 | 1.96 | 1.26 | -0.42 |